Načítá se...
Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
Target agents such as tyrosine kinase inhibitors have improved renal cell carcinoma (RCC) patient outcomes. However, complete remission (CR) with target agents is rare. Furthermore, CR of bone metastasis is much less common. We report a case of CR in bone and lung metastatic RCC. Radical nephrectomy...
Uloženo v:
| Vydáno v: | Urol Case Rep |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7184521/ https://ncbi.nlm.nih.gov/pubmed/32368498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2020.101213 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|